39P A validation study of a self-testing capillary kit, the rhelise kit for therapeutic dose monitoring (TDM) of tamoxifen, Z-endoxifen, and 4-hydroxytamoxifen in breast cancer patients
| Autor: | Hedayati, E., Shabo, I., Rydberg, P., Rehnmark, S., Randahl, H., Lindqvist, A., Hall, P.F., Bergqvist, J., Wengström, Y. |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|